Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Valion Bio, Inc. (VBIO : NSDQ)

• Company Description    Tivic Health Systems Inc. is a commercial-phase healthtech company advancing bioelectronic medicine to deliver non-invasive solutions which treat disease, increase wellness and improve lives. Its first product includes ClearUP(R). Tivic Health Systems Inc. is based in MENLO PARK, Calif. Number of Employees: 52

• Price / Volume Information    Yesterday's Closing Price: $0.85 Daily Weekly Monthly 20 Day Moving Average: 323,398 shares Shares Outstanding: 3.20 (millions) Market Capitalization: $2.73 (millions) Beta: 1.86 52 Week High: $4.60 52 Week Low: $0.72 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -23.89% -27.61% 12 Week 1.84% -5.85% Year To Date -41.21% -44.28%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1305 E. Houston St. Building 1 Suite 311 - San Antonio,TX 78205 USA ph: 888-276-6888 fax: - None http://www.tivichealth.com

• General Corporate Information    Officers Michael K. Handley - Chief Executive Officer Sheryle Bolton - Chairman Lisa Wolf - Chief Financial Officer Christina Valauri - Director Dean Zikria - Director Peer Information Valion Bio, Inc. (CORR.) Valion Bio, Inc. (RSPI) Valion Bio, Inc. (CGXP) Valion Bio, Inc. (BGEN) Valion Bio, Inc. (GTBP) Valion Bio, Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 888705308 SIC: 3845 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/13/26 Share - Related Items Shares Outstanding: 3.20 Most Recent Split Date: 3.00 (0.06:1) Beta: 1.86 Market Capitalization: $2.73 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/13/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.25 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 11.51% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: 15.87% vs. Previous Quarter: 69.77% ROE 03/31/26 - -138.10 12/31/25 - -111.60 09/30/25 - -170.27 ROA 03/31/26 - -63.67 12/31/25 - -70.44 09/30/25 - -145.97 Current Ratio 03/31/26 - 3.31 12/31/25 - 20.13 09/30/25 - 5.86 Quick Ratio 03/31/26 - 3.02 12/31/25 - 20.13 09/30/25 - 5.86 Operating Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Net Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Pre-Tax Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Book Value 03/31/26 - 3.46 12/31/25 - 6.65 09/30/25 - 3.36 Inventory Turnover 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - -0.24 Debt-to-Equity 03/31/26 - 0.62 12/31/25 - 0.38 09/30/25 - 0.00 Debt-to-Capital 03/31/26 - 27.11 12/31/25 - 21.08 09/30/25 - 0.00

Powered by Zacks Investment Research ©